• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad, June 17

Divi's Laboratories Ltd, the Hyderabad-based active pharmaceutical ingredients and intermediates company, has achieved a significant growth in turnover and net profit for fiscal ended March 2006. The board meeting on Saturday recommended a dividend of 100 per cent on equity shares of Rs 10 each for the year. For the fourth quarter under review, the company posted a turnover of Rs 129.67 crore against Rs 115.12 crore in the corresponding quarter of the previous fiscal and a net profit of Rs 22.89 crore (Rs 22.96 crore). For the full year, it posted a turnover of Rs 391.73 crore (Rs 364.52 crore) and a net profit of Rs 70.47 crore (Rs 66.03 crore), yielding an EPS of Rs 54.98 (Rs 51.51) on an equity of Rs 12.81 crore.

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Divi's Labs net up, to pay 100 pc

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line